• The origin of COVID: Did people or nature open Pandora's box at Wuhan?

    From Ubiquitous@21:1/5 to All on Tue May 11 21:05:02 2021
    XPost: alt.tv.pol-incorrect, alt.fan.rush-limbaugh, alt.politics.usa
    XPost: sci.med.diseases

    Members of the World Health Organization (WHO) team investigating the origins of the COVID-19 coronavirus arrive by car at the Wuhan Institute of Virology
    on February 3. (Photo by HECTOR RETAMAL/AFP via Getty Images)

    The COVID-19 pandemic has disrupted lives the world over for more than a
    year. Its death toll will soon reach three million people. Yet the origin of pandemic remains uncertain: The political agendas of governments and
    scientists have generated thick clouds of obfuscation, which the mainstream press seems helpless to dispel.

    In what follows I will sort through the available scientific facts, which
    hold many clues as to what happened, and provide readers with the evidence to make their own judgments. I will then try to assess the complex issue of
    blame, which starts with, but extends far beyond, the government of China.

    By the end of this article, you may have learned a lot about the molecular biology of viruses. I will try to keep this process as painless as possible. But the science cannot be avoided because for now, and probably for a long
    time hence, it offers the only sure thread through the maze.

    The virus that caused the pandemic is known officially as SARS-CoV-2, but can be called SARS2 for short. As many people know, there are two main theories about its origin. One is that it jumped naturally from wildlife to people.
    The other is that the virus was under study in a lab, from which it escaped.
    It matters a great deal which is the case if we hope to prevent a second such occurrence.


    I’ll describe the two theories, explain why each is plausible, and then ask which provides the better explanation of the available facts. It’s important
    to note that so far there is no direct evidence for either theory. Each
    depends on a set of reasonable conjectures but so far lacks proof. So I have only clues, not conclusions, to offer. But those clues point in a specific direction. And having inferred that direction, I’m going to delineate some of the strands in this tangled skein of disaster.

    A tale of two theories. After the pandemic first broke out in December 2019, Chinese authorities reported that many cases had occurred in the wet market —
    a place selling wild animals for meat — in Wuhan. This reminded experts of
    the SARS1 epidemic of 2002, in which a bat virus had spread first to civets,
    an animal sold in wet markets, and from civets to people. A similar bat virus caused a second epidemic, known as MERS, in 2012. This time the intermediary host animal was camels.

    The decoding of the virus’s genome showed it belonged a viral family known as beta-coronaviruses, to which the SARS1 and MERS viruses also belong. The relationship supported the idea that, like them, it was a natural virus that had managed to jump from bats, via another animal host, to people. The wet market connection, the major point of similarity with the SARS1 and MERS epidemics, was soon broken: Chinese researchers found earlier cases in Wuhan with no link to the wet market. But that seemed not to matter when so much further evidence in support of natural emergence was expected shortly.

    Wuhan, however, is home of the Wuhan Institute of Virology, a leading world center for research on coronaviruses. So the possibility that the SARS2 virus had escaped from the lab could not be ruled out. Two reasonable scenarios of origin were on the table.

    From early on, public and media perceptions were shaped in favor of the
    natural emergence scenario by strong statements from two scientific groups. These statements were not at first examined as critically as they should have been.

    “We stand together to strongly condemn conspiracy theories suggesting that COVID-19 does not have a natural origin,” a group of virologists and others wrote in the Lancet on February 19, 2020, when it was really far too soon for anyone to be sure what had happened. Scientists “overwhelmingly conclude that this coronavirus originated in wildlife,” they said, with a stirring rallying call for readers to stand with Chinese colleagues on the frontline of
    fighting the disease.

    Contrary to the letter writers’ assertion, the idea that the virus might have escaped from a lab invoked accident, not conspiracy. It surely needed to be explored, not rejected out of hand. A defining mark of good scientists is
    that they go to great pains to distinguish between what they know and what
    they don’t know. By this criterion, the signatories of the Lancet letter were behaving as poor scientists: They were assuring the public of facts they
    could not know for sure were true.

    It later turned out that the Lancet letter had been organized and drafted by Peter Daszak, president of the EcoHealth Alliance of New York. Daszak’s organization funded coronavirus research at the Wuhan Institute of Virology.
    If the SARS2 virus had indeed escaped from research he funded, Daszak would
    be potentially culpable. This acute conflict of interest was not declared to the Lancet’s readers. To the contrary, the letter concluded, “We declare no competing interests.”

    Peter Daszak, a member of the World Health Organization (WHO) team investigating the origins of the COVID-19 coronavirus, talks on his cellphone at the Hilton Wuhan Optics Valley in Wuhan. (Photo by HECTOR RETAMAL/AFP via Getty Images)
    Virologists like Daszak had much at stake in the assigning of blame for the pandemic. For 20 years, mostly beneath the public’s attention, they had been playing a dangerous game. In their laboratories they routinely created
    viruses more dangerous than those that exist in nature. They argued that they could do so safely, and that by getting ahead of nature they could predict
    and prevent natural “spillovers,” the cross-over of viruses from an animal
    host to people. If SARS2 had indeed escaped from such a laboratory
    experiment, a savage blowback could be expected, and the storm of public indignation would affect virologists everywhere, not just in China. “It would shatter the scientific edifice top to bottom,” an MIT Technology Review
    editor, Antonio Regalado, said in March 2020.

    A second statement that had enormous influence in shaping public attitudes
    was a letter (in other words an opinion piece, not a scientific article) published on 17 March 2020 in the journal Nature Medicine. Its authors were a group of virologists led by Kristian G. Andersen of the Scripps Research Institute. “Our analyses clearly show that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus,” the five virologists declared in the second paragraph of their letter.

    Unfortunately, this was another case of poor science, in the sense defined above. True, some older methods of cutting and pasting viral genomes retain tell-tale signs of manipulation. But newer methods, called “no-see-um” or “seamless” approaches, leave no defining marks. Nor do other methods for manipulating viruses such as serial passage, the repeated transfer of viruses from one culture of cells to another. If a virus has been manipulated,
    whether with a seamless method or by serial passage, there is no way of
    knowing that this is the case. Andersen and his colleagues were assuring
    their readers of something they could not know.

    The discussion part of their letter begins, “It is improbable that SARS-CoV-2 emerged through laboratory manipulation of a related SARS-CoV-like coronavirus.” But wait, didn’t the lead say the virus had clearly not been manipulated? The authors’ degree of certainty seemed to slip several notches when it came to laying out their reasoning.

    The reason for the slippage is clear once the technical language has been penetrated. The two reasons the authors give for supposing manipulation to be improbable are decidedly inconclusive.

    First, they say that the spike protein of SARS2 binds very well to its
    target, the human ACE2 receptor, but does so in a different way from that
    which physical calculations suggest would be the best fit. Therefore the
    virus must have arisen by natural selection, not manipulation.

    If this argument seems hard to grasp, it’s because it’s so strained. The authors’ basic assumption, not spelt out, is that anyone trying to make a bat virus bind to human cells could do so in only one way. First they would calculate the strongest possible fit between the human ACE2 receptor and the spike protein with which the virus latches onto it. They would then design
    the spike protein accordingly (by selecting the right string of amino acid units that compose it). Since the SARS2 spike protein is not of this
    calculated best design, the Andersen paper says, therefore it can’t have been manipulated.

    But this ignores the way that virologists do in fact get spike proteins to
    bind to chosen targets, which is not by calculation but by splicing in spike protein genes from other viruses or by serial passage. With serial passage, each time the virus’s progeny are transferred to new cell cultures or
    animals, the more successful are selected until one emerges that makes a
    really tight bind to human cells. Natural selection has done all the heavy lifting. The Andersen paper’s speculation about designing a viral spike
    protein through calculation has no bearing on whether or not the virus was manipulated by one of the other two methods.

    The authors’ second argument against manipulation is even more contrived. Although most living things use DNA as their hereditary material, a number of viruses use RNA, DNA’s close chemical cousin. But RNA is difficult to manipulate, so researchers working on coronaviruses, which are RNA-based,
    will first convert the RNA genome to DNA. They manipulate the DNA version, whether by adding or altering genes, and then arrange for the manipulated DNA genome to be converted back into infectious RNA.

    Only a certain number of these DNA backbones have been described in the scientific literature. Anyone manipulating the SARS2 virus “would probably” have used one of these known backbones, the Andersen group writes, and since SARS2 is not derived from any of them, therefore it was not manipulated. But the argument is conspicuously inconclusive. DNA backbones are quite easy to make, so it’s obviously possible that SARS2 was manipulated using an unpublished DNA backbone.

    And that’s it. These are the two arguments made by the Andersen group in support of their declaration that the SARS2 virus was clearly not
    manipulated. And this conclusion, grounded in nothing but two inconclusive speculations, convinced the world’s press that SARS2 could not have escaped from a lab. A technical critique of the Andersen letter takes it down in harsher words.

    Science is supposedly a self-correcting community of experts who constantly check each other’s work. So why didn’t other virologists point out that the Andersen group’s argument was full of absurdly large holes? Perhaps because
    in today’s universities speech can be very costly. Careers can be destroyed
    for stepping out of line. Any virologist who challenges the community’s declared view risks having his next grant application turned down by the
    panel of fellow virologists that advises the government grant distribution agency.

    The Daszak and Andersen letters were really political, not scientific, statements, yet were amazingly effective. Articles in the mainstream press repeatedly stated that a consensus of experts had ruled lab escape out of the question or extremely unlikely. Their authors relied for the most part on the Daszak and Andersen letters, failing to understand the yawning gaps in their arguments. Mainstream newspapers all have science journalists on their staff, as do the major networks, and these specialist reporters are supposed to be able to question scientists and check their assertions. But the Daszak and Andersen assertions went largely unchallenged.

    Doubts about natural emergence. Natural emergence was the media’s preferred theory until around February 2021 and the visit by a World Health
    Organization (WHO) commission to China. The commission’s composition and
    access were heavily controlled by the Chinese authorities. Its members, who included the ubiquitous Daszak, kept asserting before, during, and after
    their visit that lab escape was extremely unlikely. But this was not quite
    the propaganda victory the Chinese authorities may have been hoping for. What became clear was that the Chinese had no evidence to offer the commission in support of the natural emergence theory.

    This was surprising because both the SARS1 and MERS viruses had left copious traces in the environment. The intermediary host species of SARS1 was identified within four months of the epidemic’s outbreak, and the host of
    MERS within nine months. Yet some 15 months after the SARS2 pandemic began,
    and after a presumably intensive search, Chinese researchers had failed to
    find either the original bat population, or the intermediate species to which SARS2 might have jumped, or any serological evidence that any Chinese population, including that of Wuhan, had ever been exposed to the virus prior to December 2019. Natural emergence remained a conjecture which, however plausible to begin with, had gained not a shred of supporting evidence in
    over a year.

    And as long as that remains the case, it’s logical to pay serious attention
    to the alternative conjecture, that SARS2 escaped from a lab.

    Why would anyone want to create a novel virus capable of causing a pandemic? Ever since virologists gained the tools for manipulating a virus’s genes,
    they have argued they could get ahead of a potential pandemic by exploring
    how close a given animal virus might be to making the jump to humans. And
    that justified lab experiments in enhancing the ability of dangerous animal viruses to infect people, virologists asserted.

    With this rationale, they have recreated the 1918 flu virus, shown how the almost extinct polio virus can be synthesized from its published DNA
    sequence, and introduced a smallpox gene into a related virus.

    These enhancements of viral capabilities are known blandly as gain-of-
    function experiments. With coronaviruses, there was particular interest in
    the spike proteins, which jut out all around the spherical surface of the
    virus and pretty much determine which species of animal it will target. In
    2000 Dutch researchers, for instance, earned the gratitude of rodents everywhere by genetically engineering the spike protein of a mouse
    coronavirus so that it would attack only cats.

    The spike proteins on the coronavirus’s surface determine which animal it can infect. Image credit: CDC.gov
    Virologists started studying bat coronaviruses in earnest after these turned out to be the source of both the SARS1 and MERS epidemics. In particular, researchers wanted to understand what changes needed to occur in a bat
    virus’s spike proteins before it could infect people.

    Researchers at the Wuhan Institute of Virology, led by China’s leading expert on bat viruses, Shi Zheng-li or “Bat Lady,” mounted frequent expeditions to
    the bat-infested caves of Yunnan in southern China and collected around a hundred different bat coronaviruses.

    Shi then teamed up with Ralph S. Baric, an eminent coronavirus researcher at the University of North Carolina. Their work focused on enhancing the ability of bat viruses to attack humans so as to “examine the emergence potential
    (that is, the potential to infect humans) of circulating bat CoVs [coronaviruses].” In pursuit of this aim, in November 2015 they created a
    novel virus by taking the backbone of the SARS1 virus and replacing its spike protein with one from a bat virus (known as SHC014-CoV). This manufactured virus was able to infect the cells of the human airway, at least when tested against a lab culture of such cells.

    The SHC014-CoV/SARS1 virus is known as a chimera because its genome contains genetic material from two strains of virus. If the SARS2 virus were to have been cooked up in Shi’s lab, then its direct prototype would have been the SHC014-CoV/SARS1 chimera, the potential danger of which concerned many observers and prompted intense discussion.

    “If the virus escaped, nobody could predict the trajectory,” said Simon Wain-Hobson, a virologist at the Pasteur Institute in Paris.

    Baric and Shi referred to the obvious risks in their paper but argued they should be weighed against the benefit of foreshadowing future spillovers. Scientific review panels, they wrote, “may deem similar studies building chimeric viruses based on circulating strains too risky to pursue.” Given various restrictions being placed on gain-of function (GOF) research, matters had arrived in their view at “a crossroads of GOF research concerns; the potential to prepare for and mitigate future outbreaks must be weighed
    against the risk of creating more dangerous pathogens. In developing policies moving forward, it is important to consider the value of the data generated
    by these studies and whether these types of chimeric virus studies warrant further investigation versus the inherent risks involved.”

    That statement was made in 2015. From the hindsight of 2021, one can say that the value of gain-of-function studies in preventing the SARS2 epidemic was zero. The risk was catastrophic, if indeed the SARS2 virus was generated in a gain-of-function experiment.

    Inside the Wuhan Institute of Virology. Baric had developed, and taught Shi,
    a general method for engineering bat coronaviruses to attack other species.
    The specific targets were human cells grown in cultures and humanized mice. These laboratory mice, a cheap and ethical stand-in for human subjects, are genetically engineered to carry the human version of a protein called ACE2
    that studs the surface of cells that line the airways.

    Shi returned to her lab at the Wuhan Institute of Virology and resumed the
    work she had started on genetically engineering coronaviruses to attack human cells. How can we be so sure?

    A May 20, 2020, photo of the Wuhan Institute of Virology in Wuhan, where research on bat coronaviruses was conducted. (Photo by Kyodo News via Getty Images)
    Because, by a strange twist in the story, her work was funded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the US
    National Institutes of Health (NIH). And grant proposals that funded her
    work, which are a matter of public record, specify exactly what she planned
    to do with the money.

    The grants were assigned to the prime contractor, Daszak of the EcoHealth Alliance, who subcontracted them to Shi. Here are extracts from the grants
    for fiscal years 2018 and 2019. (“CoV” stands for coronavirus and “S protein” refers to the virus’s spike protein.)

    “Test predictions of CoV inter-species transmission. Predictive models of
    host range (i.e. emergence potential) will be tested experimentally using reverse genetics, pseudovirus and receptor binding assays, and virus
    infection experiments across a range of cell cultures from different species and humanized mice.”

    “We will use S protein sequence data, infectious clone technology, in vitro
    and in vivo infection experiments and analysis of receptor binding to test
    the hypothesis that % divergence thresholds in S protein sequences predict spillover potential.”

    What this means, in non-technical language, is that Shi set out to create
    novel coronaviruses with the highest possible infectivity for human cells.
    Her plan was to take genes that coded for spike proteins possessing a variety of measured affinities for human cells, ranging from high to low. She would insert these spike genes one by one into the backbone of a number of viral genomes (“reverse genetics” and “infectious clone technology”), creating a series of chimeric viruses. These chimeric viruses would then be tested for their ability to attack human cell cultures (“in vitro”) and humanized mice (“in vivo”). And this information would help predict the likelihood of “spillover,” the jump of a coronavirus from bats to people.

    The methodical approach was designed to find the best combination of coronavirus backbone and spike protein for infecting human cells. The
    approach could have generated SARS2-like viruses, and indeed may have created the SARS2 virus itself with the right combination of virus backbone and spike protein.

    It cannot yet be stated that Shi did or did not generate SARS2 in her lab because her records have been sealed, but it seems she was certainly on the right track to have done so. “It is clear that the Wuhan Institute of
    Virology was systematically constructing novel chimeric coronaviruses and was assessing their ability to infect human cells and human-ACE2-expressing
    mice,” says Richard H. Ebright, a molecular biologist at Rutgers University
    and leading expert on biosafety.

    “It is also clear,” Ebright said, “that, depending on the constant genomic contexts chosen for analysis, this work could have produced SARS-CoV-2 or a proximal progenitor of SARS-CoV-2.” “Genomic context” refers to the
    particular viral backbone used as the testbed for the spike protein.

    The lab escape scenario for the origin of the SARS2 virus, as should by now
    be evident, is not mere hand-waving in the direction of the Wuhan Institute
    of Virology. It is a detailed proposal, based on the specific project being funded there by the NIAID.

    Even if the grant required the work plan described above, how can we be sure that the plan was in fact carried out? For that we can rely on the word of Daszak, who has been much protesting for the last 15 months that lab escape
    was a ludicrous conspiracy theory invented by China-bashers.

    On December 9, 2019, before the outbreak of the pandemic became generally known, Daszak gave an interview in which he talked in glowing terms of how researchers at the Wuhan Institute of Virology had been reprogramming the
    spike protein and generating chimeric coronaviruses capable of infecting humanized mice.

    “And we have now found, you know, after 6 or 7 years of doing this, over 100 new SARS-related coronaviruses, very close to SARS,” Daszak says around
    minute 28 of the interview. “Some of them get into human cells in the lab,
    some of them can cause SARS disease in humanized mice models and are untreatable with therapeutic monoclonals and you can’t vaccinate against them with a vaccine. So, these are a clear and present danger….

    “Interviewer: You say these are diverse coronaviruses and you can’t vaccinate against them, and no anti-virals — so what do we do?

    “Daszak: Well I think…coronaviruses — you can manipulate them in the lab
    pretty easily. Spike protein drives a lot of what happen with coronavirus, in zoonotic risk. So you can get the sequence, you can build the protein, and we work a lot with Ralph Baric at UNC to do this. Insert into the backbone of another virus and do some work in the lab. So you can get more predictive
    when you find a sequence. You’ve got this diversity. Now the logical progression for vaccines is, if you are going to develop a vaccine for SARS, people are going to use pandemic SARS, but let’s insert some of these other things and get a better vaccine.” The insertions he referred to perhaps included an element called the furin cleavage site, discussed below, which greatly increases viral infectivity for human cells.

    In disjointed style, Daszak is referring to the fact that once you have generated a novel coronavirus that can attack human cells, you can take the spike protein and make it the basis for a vaccine.

    One can only imagine Daszak’s reaction when he heard of the outbreak of the epidemic in Wuhan a few days later. He would have known better than anyone
    the Wuhan Institute’s goal of making bat coronaviruses infectious to humans,
    as well as the weaknesses in the institute’s defense against their own researchers becoming infected.

    But instead of providing public health authorities with the plentiful information at his disposal, he immediately launched a public relations campaign to persuade the world that the epidemic couldn’t possibly have been caused by one of the institute’s souped-up viruses. “The idea that this virus escaped from a lab is just pure baloney. It’s simply not true,” he declared
    in an April 2020 interview.

    The safety arrangements at the Wuhan Institute of Virology. Daszak was
    possibly unaware of, or perhaps he knew all too well, the long history of viruses escaping from even the best run laboratories. The smallpox virus escaped three times from labs in England in the 1960’s and 1970’s, causing 80 cases and 3 deaths. Dangerous viruses have leaked out of labs almost every
    year since. Coming to more recent times, the SARS1 virus has proved a true escape artist, leaking from laboratories in Singapore, Taiwan, and no less
    than four times from the Chinese National Institute of Virology in Beijing.

    One reason for SARS1 being so hard to handle is that there were no vaccines available to protect laboratory workers. As Daszak mentioned in the December
    19 interview quoted above, the Wuhan researchers too had been unable to
    develop vaccines against the coronaviruses they had designed to infect human cells. They would have been as defenseless against the SARS2 virus, if it
    were generated in their lab, as their Beijing colleagues were against SARS1.

    A second reason for the severe danger of novel coronaviruses has to do with
    the required levels of lab safety. There are four degrees of safety,
    designated BSL1 to BSL4, with BSL4 being the most restrictive and designed
    for deadly pathogens like the Ebola virus.

    The Wuhan Institute of Virology had a new BSL4 lab, but its state of
    readiness considerably alarmed the State Department inspectors who visited it from the Beijing embassy in 2018. “The new lab has a serious shortage of appropriately trained technicians and investigators needed to safely operate this high-containment laboratory,” the inspectors wrote in a cable of January 19, 2018.

    The real problem, however, was not the unsafe state of the Wuhan BSL4 lab but the fact that virologists worldwide don’t like working in BSL4 conditions.
    You have to wear a space suit, do operations in closed cabinets, and accept that everything will take twice as long. So the rules assigning each kind of virus to a given safety level were laxer than some might think was prudent.

    Before 2020, the rules followed by virologists in China and elsewhere
    required that experiments with the SARS1 and MERS viruses be conducted in
    BSL3 conditions. But all other bat coronaviruses could be studied in BSL2,
    the next level down. BSL2 requires taking fairly minimal safety precautions, such as wearing lab coats and gloves, not sucking up liquids in a pipette,
    and putting up biohazard warning signs. Yet a gain-of-function experiment conducted in BSL2 might produce an agent more infectious than either SARS1 or MERS. And if it did, then lab workers would stand a high chance of infection, especially if unvaccinated.

    Much of Shi’s work on gain-of-function in coronaviruses was performed at the BSL2 safety level, as is stated in her publications and other documents. She has said in an interview with Science magazine that “[t]he coronavirus
    research in our laboratory is conducted in BSL-2 or BSL-3 laboratories.”

    “It is clear that some or all of this work was being performed using a biosafety standard — biosafety level 2, the biosafety level of a standard US dentist’s office — that would pose an unacceptably high risk of infection of laboratory staff upon contact with a virus having the transmission properties of SARS-CoV-2,” Ebright says.

    “It also is clear,” he adds, “that this work never should have been funded
    and never should have been performed.”

    This is a view he holds regardless of whether or not the SARS2 virus ever saw the inside of a lab.

    Concern about safety conditions at the Wuhan lab was not, it seems,
    misplaced. According to a fact sheet issued by the State Department on
    January 21, 2021, “The U.S. government has reason to believe that several researchers inside the WIV became sick in autumn 2019, before the first identified case of the outbreak, with symptoms consistent with both COVID-19 and common seasonal illnesses.”

    David Asher, a fellow of the Hudson Institute and former consultant to the State Department, provided more detail about the incident at a seminar. Knowledge of the incident came from a mix of public information and “some
    high end information collected by our intelligence community,” he said. Three people working at a BSL3 lab at the institute fell sick within a week of each other with severe symptoms that required hospitalization. This was “the first known cluster that we’re aware of, of victims of what we believe to be COVID-19.” Influenza could not completely be ruled out but seemed unlikely in the circumstances, he said.

    Comparing the rival scenarios of SARS2 origin. The evidence above adds up to
    a serious case that the SARS2 virus could have been created in a lab, from which it then escaped. But the case, however substantial, falls short of
    proof. Proof would consist of evidence from the Wuhan Institute of Virology,
    or related labs in Wuhan, that SARS2 or a predecessor virus was under development there. For lack of access to such records, another approach is to take certain salient facts about the SARS2 virus and ask how well each is explained by the two rival scenarios of origin, those of natural emergence
    and lab escape. Here are four tests of the two hypotheses. A couple have some technical detail, but these are among the most persuasive for those who may care to follow the argument.

    1) The place of origin. Start with geography. The two closest known relatives of the SARS2 virus were collected from bats living in caves in Yunnan, a province of southern China. If the SARS2 virus had first infected people
    living around the Yunnan caves, that would strongly support the idea that the virus had spilled over to people naturally. But this isn’t what happened. The pandemic broke out 1,500 kilometers away, in Wuhan.

    Beta-coronaviruses, the family of bat viruses to which SARS2 belongs, infect the horseshoe bat Rhinolophus affinis, which ranges across southern China.
    The bats’ range is 50 kilometers, so it’s unlikely that any made it to Wuhan. In any case, the first cases of the COVID-19 pandemic probably occurred in September, when temperatures in Hubei province are already cold enough to
    send bats into hibernation.

    What if the bat viruses infected some intermediate host first? You would need
    a longstanding population of bats in frequent proximity with an intermediate host, which in turn must often cross paths with people. All these exchanges
    of virus must take place somewhere outside Wuhan, a busy metropolis which so far as is known is not a natural habitat of Rhinolophus bat colonies. The infected person (or animal) carrying this highly transmissible virus must
    have traveled to Wuhan without infecting anyone else. No one in his or her family got sick. If the person jumped on a train to Wuhan, no fellow
    passengers fell ill.

    It’s a stretch, in other words, to get the pandemic to break out naturally outside Wuhan and then, without leaving any trace, to make its first
    appearance there.

    For the lab escape scenario, a Wuhan origin for the virus is a no-brainer. Wuhan is home to China’s leading center of coronavirus research where, as
    noted above, researchers were genetically engineering bat coronaviruses to attack human cells. They were doing so under the minimal safety conditions of
    a BSL2 lab. If a virus with the unexpected infectiousness of SARS2 had been generated there, its escape would be no surprise.

    2) Natural history and evolution. The initial location of the pandemic is a small part of a larger problem, that of its natural history. Viruses don’t
    just make one time jumps from one species to another. The coronavirus spike protein, adapted to attack bat cells, needs repeated jumps to another

    [continued in next message]

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)